In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor
Year: 2007
Type: article
Abstract: The diarylquinoline R207910 is in clinical development for tuberculosis treatment. The MIC(50) for 41 drug-susceptible and 44 multidrug-resistant Mycobacterium tuberculosis clinical isolates was 0.032 microg/ml. Out of 20 additional mycobacterial species, three were found to be naturally resistant to R207910 and were shown to exhibit a polymorphism in their atpE genes.
DOI: 10.1128/aac.00181-07
Institution: Karolinska Institutet
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2159526017
